Méhnyakrák: vizsgálatok itt: Kína
159 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleSKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
- Where
- Dalian, Fuzhou, Guangzhou, Hohhot, Jinan, Jining, Nanning, Qingdao, Taiyuan, Zhangzhou
- Életkor
- 18 év and over
- People
- 89
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT07256236 - No phaseTaking peopleModified Tumor-free Techniques Operation to Cervical Cancer
- Where
- Beijing, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Lanzhou, Nanchong, Shanghai, Shijiazhuang, Tianjin, Wuhan, Xi’an, Xianyang
- Életkor
- 18 év to 65 év
- People
- 524
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06836869 - 2. fázisNot yet taking people in KínaJSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer
- Where
- Guangzhou, Hangzhou
- Életkor
- 18 év and over
- People
- 78
- Run by
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
See details and how to joinNCT07497074 - No phaseNot yet taking people in KínaA Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Jin LI
See details and how to joinNCT07466901 - 1/2. fázisTaking peopleCarbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
- Where
- Beijing, Chengdu, Chongqing, Fuzhou, Haikou, Heilongjiang, Henan, Hunan, Shanghai
- Életkor
- 18 év to 80 év
- People
- 54
- Run by
- Sichuan Enray Pharmaceutical Sciences Company
See details and how to joinNCT07433283 - No phaseTaking peopleTranscutaneous Electrical Acupoint Stimulation for Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 70 év
- People
- 76
- Run by
- Lu Chao
See details and how to joinNCT07235371 - 2. fázisNot yet taking people in KínaA Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 32
- Run by
- Zhongnan Hospital
See details and how to joinNCT07363330 - 2. fázisTaking peopleA Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 96
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07054567 - 2. fázisNot yet taking people in KínaA Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 25
- Run by
- Zheng Min
See details and how to joinNCT07348861 - 1. fázisTaking peopleThe Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 97
- Run by
- Tongji Hospital
See details and how to joinNCT06552598 - 2. fázisTaking peopleSerplulimab for Locally Advanced Cervical Cancer
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 216
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07340489 - 2. fázisTaking peopleOnline Adaptive Radiotherapy for Cervical Cancer
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 124
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06562166 - 2. fázisTaking peopleSerplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
- Where
- Tianjin
- Életkor
- 18 év to 65 év
- People
- 134
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06727617 - 1/2. fázisTaking peopleStudy of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06938880 - 1/2. fázisTaking peopleStudy of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07080216 - 2. fázisTaking peopleChemo-immunotherapy for Cervical Cancer Stage IIICp Trial
- Where
- Hangzhou
- Életkor
- 18 év to 70 év
- People
- 59
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT07167160 - 2. fázisTaking peopleQL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 50
- Run by
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
See details and how to joinNCT07286253 - No phaseTaking peopleThe Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 50
- Run by
- SHUANG ZHENG JIA, PhD
See details and how to joinNCT06349148 - 2. fázisTaking peopleIparomlimab/Tuvonralimab Injection Plus CCRT in LACC
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07232654 - 1. fázisTaking peopleStudy of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- Therorna
See details and how to joinNCT07081984 - 2. fázisNot yet taking people in KínaNeoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 42
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT07244965 - 2. fázisTaking peopleA Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer
- Where
- Fuzhou, Jinan
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07051486 - 1/2. fázisNot yet taking people in KínaPenfluridol for Relapsed/Refractory Small Cell Cancers
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 33
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07206563 - 1/2. fázisTaking peopleA Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 38
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05803018 - 2. fázisTaking peopleA Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 130
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05990803